|Science Projects||Project Guides||Ask An Expert||Blog||Science Careers||Teachers||Parents||Students|
November 19, 2018
Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes. Read more
Reading level: College
EurekAlert!, the online, global news service operated by AAAS, the science society
Please Give Us Feedback!